Induction of Retinoid Resistance by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia After Remission

References

• Huang M.E., Ye Y.I., Chen S.R., Chai J.R., Lu J.X., Zhoa L., Gu L.J., Wang Z.Y. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–571
   PubMed Web of Science ®Google Scholar
• Castaiene S., Chomienne C., Daniel M.T., Fenaux P., Berger R., Degos L. All-trans retinoic acid as a differentiation therapy in acute promyelocytic leukemias, I. Clinicals results. Blood 1990; 76: 1704–1707
   PubMed Web of Science ®Google Scholar
• Warrel R.P., Jr., Frankel S.R., Miller W.H., Scheinberg D.A., Itri L.M., Hittelman W.N., Vyas R., Andreff A., Tafudi A., Jakubowski A., Gabrilove J., Gordon M., Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl, J. Med. 1991; 324: 1385–1393
   PubMed Web of Science ®Google Scholar
• Sun G.L., Huang Chang Y.G., Jiang G.S., Zhang T. Clinical study on all-trans retinoic acid in treatment of 544 cases of acute promyelocytic leukemia treated. Chin, J. Hematol. 1992; 13: 135–137
   Google Scholar
• Borrow J., Goddard A.D., Sheer D., Solomon E. Molecular analysis of APL breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha gene to a novel transcribed locus. Science 1990; 249: 1577–1580
   PubMed Web of Science ®Google Scholar
• de The Chomienne H.C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor-alpha gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Longo L., Pantolfi P.P., Biondi P., Biondi A., Rambaldi A., Mencarelli A., Lo C OC, O F., Diverio D., Pegoraro C., Avanzi G., Tabilio A., Donti E., Grignani F., Pellici P.G. Rearrangement and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. J. Exp. Med. 1990; 172: 1571–1575
   PubMed Web of Science ®Google Scholar
• Wolbach S.B., Howe P.R. Tissue changes following deprivation of fat soluble A vitamin. J. Exp. Med. 1925; 42: 753–777
   PubMedGoogle Scholar
• Osborne T.B., Mendel L.B. The relation of growth to the chemical constituents of the diet. J. Biol. Chem. 1913; 15: 311–326
   Google Scholar
• Silverman A., Ellis C., Voorhees J. Hypervitaminosis A syndrome: a paradigm of retinoid side effects. J. Am. Acad. Dermatol. 1987; 16: 1027–1039
   PubMed Web of Science ®Google Scholar
• Smith S.M., Pang K., Sundin O., Wedden S.E., Thaller C., Eichele G. Molecular approaches to vertebrate limb morphogenesis. Dev. 1989; 107: S121–S131
   Google Scholar
• Sporn M.B., Roberts A.B. Role of retinoids in differentiation and carcinogenesis. Cancer Rex 1983; 43: 3034–3040
   PubMed Web of Science ®Google Scholar
• Bollag W., Holdener E.E. Retinoids in cancer prevention and therapy. J. Clin. Oncology 1992; 3: 513–526
   Google Scholar
• Kramer K.L., Di Giovanna J.J., Moshell A.N., Tarone R.E., Peck G.L. Prevention of skin cancer in Xeroderma pigmentosum with the use of oral isotretinoin. N. Engl, J. Med. 1990; 318: 1633–1637
   Web of Science ®Google Scholar
• Loran R., Clifford J.L. Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells. Biomed. Pharmaacoter. 1991; 44: 1–13
   Google Scholar
• Larson R.A., Konko K., Vardiman J.W., Butler A.E., Golomb H.M., Rowley J.D. Evidence for a translocation in every patient with acute promyelocytic leukemia. Am. J. Med. 1984; 76: 827–841
   PubMed Web of Science ®Google Scholar
• Borrow J., Solomon E. Molecular analysis of the t(l5;17) translocation in acute promyelocytic leukaemia. Bailliere 's clinical haematology/the molecular genetics of haematological malignancy, B.D. Young. W. B. Saunders, London 1992; 833–856
   Google Scholar
• Warrell R.P., Jr. Retinoid resistance in acute promyelocytic leukemia: new mechanisms strategies and implications. Blood 1993; 82: 1949, 1953
   PubMed Web of Science ®Google Scholar
• Comic M., Delva L., Castaigne S., Lefebvre P., Balitrand N., Degos L., Chomienne C. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia. Leukemia 1994; 8: 914–917
   PubMed Web of Science ®Google Scholar
• Koeffler H.P., Golde D.W. Human myeloid leukemia cell lines: a review. Blood 1990; 56: 344–350
   Google Scholar
• Douer D., Koeffler H.P. Retinoic acid inhibition of the clonal growth of human myeloid leukemia cells. J. Clin. Invest. 1982; 69: 277–283
   PubMed Web of Science ®Google Scholar
• Breitman T.R., Keene B.R., Hemmi H. Retinoic acid-induced differentiation of fresh human leukaemia cells and the human myelomonocytic leukaemia cell lines, HL-60, U-937, and THP-1. Cancer Surveys 1983; 82: 265–291
   Google Scholar
• Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia. Nature 1978; 274: 535–539
   PubMed Web of Science ®Google Scholar
• Lawrence H.J., Conner K., Kelly M.A., Haussler M.R., Wallace P., Bagby G. Cis-retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. Blood 1987; 69: 302–307
   PubMed Web of Science ®Google Scholar
• Valtieri M., Boccoli G., Testa U., Barletta C., Peschle C. Two step differentiation of AML-193 leukemic line: terminal maturation is induced by positive interaction of retinoic acid with granulocyte colony stimulating factor (CSF) and vitamin D3 with monocyte CSF. Blood 1991; 77: 1804–1812
   PubMed Web of Science ®Google Scholar
• Momparler R.L., Dore B.T., Momparler L.F. Effect of 5-aza-2′-deoxycytidine and retinoic acid on differentiation and c-mye expression in HL 60 human myeloid leukemia cells. Cancer Lett. 1990; 4: 21–28
   Web of Science ®Google Scholar
• Nilsson B. Probable in vivo induction differentiation by retinoic acid of promyelocytic in acute promyelocytic leukaemia. Br. J. Haematol. 1984; 57: 365–371
   PubMed Web of Science ®Google Scholar
• Chomienne C., Ballerini P., Balidrand N., Daniel M.T., Fenaux P., Castaigne S., Degos L. All-trans- retinoic acid in acute promyelocytic leukemias, II. In vitro studies: structure-fonction relationship. Blood 1990; 76: 1710–1717
   PubMed Web of Science ®Google Scholar
• Flynn P.J., Miller W.J., Weisdorf D.J., Arthur D.C., Brunning R., Branda R.R. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. Blood 1983; 62: 1211–1217
   PubMed Web of Science ®Google Scholar
• Nilsson B., Olofsson T., Olsson I. Myeloid differentiation in liquid cultures of cells from patients with chronic myeloid leukemia: effects of retinoid acid and indomethacin. Exp. Hematol. 1991; 12: 91–99
   Google Scholar
• Strickland S., Breitman T.R., Frickel F., Nürrenbach A., Hädicke E., Sporn M.B. Structure activity relationship of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. Cancer Res. 1983; 43: 5268–5272
   PubMed Web of Science ®Google Scholar
• Tobler A., Dawson M.I., Koeffer H.P. Retinoid structure-function relationship in normal and leukemic hematopoiesis in vitro. J. Clin. Invest. 1986; 78: 303–309
   PubMed Web of Science ®Google Scholar
• Fontana J.A., Rogers J.S., Durham J.P. The role of 13-cis retinoic acid in the remission of a patient with acute promyelocytic leukemia. Cancer. 1989; 57: 209–217
   Web of Science ®Google Scholar
• Curtis J.E., Messner H.A., Minden M.D., Trichler D.L., McCullocch E.A. Improved maintenance therapy for acute myelogenous leukemia using 13-cis retinoic acid containing regimen. Proc. Am. Acad. 1989; 30: 268–272
   Google Scholar
• Runde V., Aul C., Sudhoff T., Heyll A., Schneider W. Retinoic acid in the treatment of acute promyelocytic leukemia: inefficacy of the 13-cis isomer and induction of complete remission by the all-trans isomer complicated by thromboembolic events. Ann. Hematol. 1992; 64: 270–272
   PubMed Web of Science ®Google Scholar
• McCarthy D., Samson D., Mir N., Rule S., Nadir F.K., Taylor J., Costello C. Response to trans-retinoic acid in an AML-M3 patient resistant to cis-retinoic acid. Leuk. Res. 1991; 15: 765–769
   PubMed Web of Science ®Google Scholar
• Toh C.H., Winfield D.A. All-trans retinoic acid and side-effects. Lancet 1992; 340: 1239–1240
   Web of Science ®Google Scholar
• Degos L., Chomienne C., Daniel M.T. Treatment of first relapse of acute promyelocytic leukemia using all-trans retinoic acid: a model for the differentiation therapy. Lancet 1990; 336: 1440–1441
   PubMed Web of Science ®Google Scholar
• Chen Z.X., Xue Y.Q., Zhang R., Tao R.F., Xia X.M., Li C., Wang W., Zu W.Y., Yao X.Z., Ling B.J. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991; 78: 1413–1419
   PubMed Web of Science ®Google Scholar
• Frankel S.R., Eardley A., Lauwers G., Weiss M., Warrell R.P., Jr. The “retinoic acid syndrom” in acute promyelocytic leukemia. Ann. Intern. Med. 1992; 117: 292–296
   PubMed Web of Science ®Google Scholar
• Davies P.I.A., Murtaugh M.P., Moore W.T., Johnson G.S., Lucas D. Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 1985; 260: 5166–5174
   PubMed Web of Science ®Google Scholar
• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposals for the classification of acute leukemia. Br. J. Haematol. 1976; 33: 451–45
   PubMed Web of Science ®Google Scholar
• Cordonnier C., Dreyfus F., Cassasus P., Leblond V., Pesce A., Teillet-Thibault F., Colombat P., Troussard X., Dombret H., Gouault M., Jouault H., Kuentz M., Karianakis G., Vemant J.P. Progressive induction for prevention of disseminated intravascular coagulation in acute promyelocytic leukemia: preliminary results. Infection and hemorrhage in acute leukemia, John Libbey, 1989; 81–87, Eurotext (Paris)
   Google Scholar
• Borrow J., Goddard A.D., Gibbons B., Kartz F., Swirsky D., Fioreto T., Dube I., Winfield D.A., Kingston J., Hagemeijer A., Rees J.K.L., Lister T.A., Solomon E. Diagnosis of acute promyelocytic leukaemia by RT-PCR detection of PMLRARα and RARαPML fusion transcript. Br. J. Haematol. 1992; 82: 529–534
   PubMed Web of Science ®Google Scholar
• Cunningham I., Gee T.S., Reich L., Kempin S.J., Naval A.N., Clarkson B.D. Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 1989; 73: 1116–1122
   PubMed Web of Science ®Google Scholar
• Kantarjian H.M., Keating M.J., Walters R.S. Acute promyelocytic leukemia: MDS Anderson Hospital experience. Am. J. Med. 1986; 80: 789–797
   PubMed Web of Science ®Google Scholar
• Thomas X., Archimbaud E., Treille-Ritouet D., Fiere D. Prognostic factors in acute promyelocytic leukemia: a retropective study of 67 cases. Leukemia Lymphoma 1991; 4: 249–256
   PubMed Web of Science ®Google Scholar
• Rodeghiero F., Avvisati G., Castaman G., Barbui T., Mandelli F. Early death and anti-hemorrhagic treatment in acute promyelocytic leukemia. A Gimena study on 268 patients. Blood 1990; 75: 2112–2111
   PubMed Web of Science ®Google Scholar
• Daenen S., Vellenga E., van Dobbenburgh O.A., Halie M.R. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and. Aspergillus pneumonia. Blood 1986; 67: 559–561
   Google Scholar
• Muindi J., Frankel S.R., Miller W.H., Jr., Jakubowski A., Scheinberg D.A., Young C., Dmitrovsky E., Warrell R.P., Jr. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid “resistance” in patients with acute promyelocytic leukemia. Blood 1992; 79: 299–303, Erratum, Blood, 80 855
   PubMed Web of Science ®Google Scholar
• Delva L., Comic M., Balitrand N., Guidez F., Micléa J.M., Delmer A., Teiller F., Fenaux P., Castaigne S., Degos L., Chomienne C. Resistance to All-Trans Retinoic Acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 1992; 82: 2175–2181
   Web of Science ®Google Scholar
• Fenaux P., Le Deley M.C., Castaigne S., Archimbaud E., Chomienne C., Link H., Guerci A., Duarte M., Daniel M.T., Bowen D., Huebner G., Bauters F., Fegueux N., Fey M., Sanz M., Lowenberg B., Maloisel F., Auzanneau G., Sadoun A., Gardin C., Bastion Y., Ganser A., Jacky E., Dombret H., Chastang C., Degos L. The European APL 91 group. 1993 Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomisal trial. Blood, 82: 3241–324
   PubMed Web of Science ®Google Scholar
• Groupe franĉis de cytogénétique hétologique., Acute leukemia treated with intensive chemotherapy in patients with a history of previous chemo- and/or radiotherapy: prognostic significance of karyotype and preceding myelodisplastic syndrome. Leukemia 1994; 8: 87–91
   PubMed Web of Science ®Google Scholar
• Roberts A.B., Nichols M., Newton D.L., Sporn M.B. In vitro metabolism of retinoic acid in hamster intestine and liver. J. Biol. Chem. 1979; 254: 6296–6302
   PubMed Web of Science ®Google Scholar
• Colburn W.A., Gilson D.M., Rodriguez L.C., Bugge C.J.L., Blumenthal H.P. Food increase the bioavailability of isotretinoin. J. Clin. Pharmacol. 1985; 25: 583–589
   PubMed Web of Science ®Google Scholar
• Blomhoff R., Green M.H., Berg T., Norum K. Transport and storage of vitamin A. Science 1990; 250: 399–404
   PubMed Web of Science ®Google Scholar
• Williams J.B., Napoli J.L. Metabolism of retinoic acid and retinol during differentiation of F9 embryonal carcinoma cells. Proc. Nail. Acad. Sci. 1985; 82: 4658–4662
   PubMed Web of Science ®Google Scholar
• Warrel R.P., Jr., Mundi J., Frankel S.R., Jakubowski A., Dmitrovsky E., Miller W.H. Continuous treatment with all-trans retinoic acid progressively decreases plasma drug concentrations: implications for relapse and resistance in acute promyelocytic leukemia. Blood 1991; 78: 268a
   Google Scholar
• Muindi J., Frankel S.R., Huselton C., De Grazia F., Garland W.A., Young C.W., Warrell R.P., Jr. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res. 1992; 52: 2138–2142
   PubMed Web of Science ®Google Scholar
• Lefebvre P., Thomas G., Gourmel B., Agadir A., Castaigne S., Dreux C., Degos L., Chomienne C. Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Leukemia 1991; 5: 1054–1058
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Pellici P.G., Biondi A. Clinical relevance of the PMWRARα gene rearrangement in acute promyelocytic leukaemia. Leukemia Lymphoma 1994; 12: 327–332
   PubMed Web of Science ®Google Scholar
• Chomienne C., Balitrand N., Ballerini P., Castaigne S., de The H., Degos L. All-trans retinoic acid modulates the retinoic acid receptor alpha in promyelocytic cells. J. Clin. invest. 1991; 88: 2150–2154
   PubMed Web of Science ®Google Scholar
• Giguere V., Ong E.S., Segui P., Evans R.M. Identification of a receptor for the morphogen retinoic acid. Nature 1988; 330: 624–629
   Web of Science ®Google Scholar
• Zelent A., Krust A., Petckovich M., Kastner P., Chambon P. Cloning of a murine a and p retinoic acid receptors and a novel receptor y predominantly expressed in skin. Nature 1989; 339: 714–717
   PubMed Web of Science ®Google Scholar
• Petkovitch M., Brand N.J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444–450
   PubMed Web of Science ®Google Scholar
• Brand N., Petkovitch M., Krust A., Chambon P., de The Marchio H.A., Tiollais P., Dejean A. Identification of a second human retinoic acid receptor. Nature 1988; 332: 850–853
   PubMed Web of Science ®Google Scholar
• Krust A., Kastner P.H., Petkovich M., Zelent A., Chambon P. A third human retinoic acid receptor, hRARγ. Proc. Acad. Natl. Sci. 1989; 86: 5310–5314
   PubMed Web of Science ®Google Scholar
• Evans R.M. The steroid and thyroid hormone superfamily. Science 1988; 240: 889–895
   PubMed Web of Science ®Google Scholar
• Mangelsdorf D.J., Ong E.S., Dyck J.A., Evans R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224–228
   PubMed Web of Science ®Google Scholar
• Green S., Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genetics 1988; 4: 309–314
   PubMed Web of Science ®Google Scholar
• De The H., Vivanco Del Mar, Ruiz M., Tiollais P., Stunnenberg H., Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor-a gene. Nature 1990; 343: 177–180
   PubMed Web of Science ®Google Scholar
• Yang N., Schüle R., Mangelsdorf D.J., Evans R.M. Characterization of DNA binding and retinoic acid receptor. Proc. Natl. Acad. Sci. 1991; 88: 3559–3563
   PubMed Web of Science ®Google Scholar
• Mangelsdorf D.J., Borgmeyer U., Heyman A., Zhou J.Y., Ong E.S., Oro A.E., Kakizuka A., Evans R.M. Characterization of three RXR genes that mediate the action of 9-Cis retinoic acid. Gene Dev. 1992; 6: 329–344
   PubMed Web of Science ®Google Scholar
• Kliewer S.A., Umescono K., Noonan D.J., Heyman R.A., Evans R.M. Convergence of a 9-cis retinoic acid and a peroxisome proliferator signalling pathway convergence though heterodimer formation of their receptors. Nature 1993; 358: 771–774
   Web of Science ®Google Scholar
• Zhang X.K., Hoffman B., Tan P.L.V., Graupner G., Pfahl M. Retinoic X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992; 355: 441–446
   PubMed Web of Science ®Google Scholar
• Leid M., Kastner P., Lyons R., Nakshatri H., Saunders M., Zacharewski T., Chen J.Y., Staub A., Gamier J.M., Mader S., Chambon P. Purification cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimezes to bind target sequences efficiently. Cell 1992; 68: 377–395
   PubMed Web of Science ®Google Scholar
• Yu V.C., Delsert C., Andersen B., Holloway J.M., Devary O., Nar A.M., Kim S.Y., Boutin J.M., Glass C.K., Rosenfeld M.G. RXR-β a coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell 1992; 67: 1251–1266
   Web of Science ®Google Scholar
• Yen P.M., Darling D.S., Carter R.L., Forgione M., Umeda P.K., Chin W.W. Triiodotyronine (T3) decreases binding to DNA by T3-receptor homodimers, but not receptor-auxiliary protein heterodimers. J. Biol. Chem. 1992; 267: 3565–3568
   PubMed Web of Science ®Google Scholar
• Daniel M.T., Koken M., RomagnÉbarbey O.S., Bazarbachi A., Stadler M., Guillemin M.C., Degos L., Chomienne C., de Thé H. PML protein expression, in hematopoietic and acute promyelocytic leukemic cells. Blood 1993; 82: 1858–1867
   PubMed Web of Science ®Google Scholar
• De The H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. The PML-RARα fusion generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675–484
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller W.H., Umesono K., Warrel U.P., Jr., Frankel S.R., Murty V. V. V. S., Dmitrovsky E., Evans R.M. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 1991; 66: 663–474
   PubMed Web of Science ®Google Scholar
• Pandolfi P.P., Griganani F., Alcalay M., Mencarelli A., Biondi A., Lo Coco F., Pellici P.G. Molecular structure and origin of the acute promyelocytic leukemia my1/RAR alpha cDNA and characterization of its retinoid binding and transactivation properties. Oncogene 1991; 6: 1285–1292
   PubMed Web of Science ®Google Scholar
• Pandolfi P.P., Alcalay M., Fagioli M., Zangrilli D., Mencarelli A., Diverio D., Biondi A., Lo Coco F., Rambaldi A., Grignani F., Rochette-Egly C., Gaube M.P., Chambon P., Pellici P.G. Genomic variability and alternative splicing generate multiple PMLRAR alpha transcripts that encode aberrant PML proteins and PMLRAR alpha isoforms in acute promyelocytic leukemia. EMBOJ. 1992; 11: 1397–1407
   PubMed Web of Science ®Google Scholar
• Nervi C., Poindoxter E.C., Grignani F., Pandolfi P.P., Lo Coco F., Avvisati G., Pellici P.G., Jetten A.M. Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia specific t(15; 17) translocation. Cancer Rex 1992; 52: 3687–3692
   PubMed Web of Science ®Google Scholar
• Dermine S., Grignani F., Clerici M., Nervi C., Sozzi G., Talamo G.P., Marchesi E., Formelli F., Parmiani G., Pellici Gambaccorti- P.G., Passerini C. Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PMLlRARα protein. Blood 1993; 82: 1573–1577
   PubMed Web of Science ®Google Scholar
• Duprez E., Ruchaud S., House G., Martin-Thouvenin V., Valensi F., Kastner P., Berger R., Lanotte M. A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: Isolation, morphological, immunological, and molecular features. Leukemia 1992; 6: 1281–1287
   PubMed Web of Science ®Google Scholar
• Ong D.E., Chytil F. Cellular retinoic acid-binding protein from rats testis. J. Biol. Chem. 1978; 253: 4551–4554
   PubMed Web of Science ®Google Scholar
• Giguere V., Lyn S., Yip P., Siu C.H., Amin S. Molecular cloning of cDNA encoding a second cellular retinoic acid binding protein. Proc. Natl. Acad. Sci. 1990; 87: 6233–6237
   PubMed Web of Science ®Google Scholar
• Aström A., Tavakkol A., Petterson U., Cromie M., Elder J.T., Voorhees J. Molecular cloning of two human cellular retinoic acid-binding protein. J Biol. Chem. 1991; 266: 17662–17666
   PubMed Web of Science ®Google Scholar
• Sundelin J., Das S.R., Heriksson U., Rask L., Paterson P.A. The primary structure of bovine cellular retinoic acid-binding protein. J Biol. Chem. 1985; 260: 6494–4499
   PubMed Web of Science ®Google Scholar
• Darmon M., Rocher M., Carvey M.T., Martin B., Ribald T., Delescluse C., Shroot B. Biological activity of retinoids correlates with affinity for nuclear receptors but not for cytosolic binding protein. Skin Pharmacol. 1988; 1: 161–175
   PubMedGoogle Scholar
• Jetten A.M., Anderson K., Deas M.A., Kagechika H., Lotan R., Reatrick J.I., Shuddo K. New benzoic acid derivatives with retinoid activity: lack of direct correlation between biological activity and binding to cellular retinoic acid binding protein. Cancer Res. 1987; 47: 323–3527
   PubMedGoogle Scholar
• Maden M., Ong D.E., Summerbell D., Chytil F. Spatial distribution of cellular protein binding to retinoic acid in the chick limb bud. Nature 1988; 335: 733–73
   PubMed Web of Science ®Google Scholar
• Ruberte E., Dolle P., Chambon P., Morriss-Kay G. Retinoic acid receptors and cellular retinoid binding proteins, II. Their differential pattern of transcription during early morphogenesis in mouse embryos. Dev. 1991; 111: 45–60
   PubMed Web of Science ®Google Scholar
• Stoner C.M., Gudas L.J. Mouse cellular retinoic acid binding protein: cloning, complementary DN A sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA–3–10 mutant teratocarcinoma cells. Cancer Res. 1989; 49: 1497–1504
   PubMed Web of Science ®Google Scholar
• Fiorella P.D., Napoli J.L. Expression of Cellular Retinoic Acid Binding Protein (CRABP) in Escherichia coli: Characterization and evidence that holo-CRABP is a substrate in retinoic acid metabolism. J. Biol. Chem. 1991; 266: 16572–16576
   PubMed Web of Science ®Google Scholar
• Boylan J.F., Gudas L. The level of CRABP-I expression influences the amounts and types of all-trans retinoic acid metabolites in F9 teratocarcinoma stem cells. J. Biol. Chem. 1992; 267: 21486–21491
   PubMed Web of Science ®Google Scholar
• Comic M., Delva L., Guidez F., Balitrand N., Degos L., Chomienne C. Induction of retinoic acid binding protein in norman and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res 1992; 52: 3329–3334
   PubMed Web of Science ®Google Scholar
• Durand B., Saunders M., Leroy P., Leid M., Chambon P. All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DRI and DR2 repeats motifs. Cell 1992; 71: 73–85
   PubMed Web of Science ®Google Scholar
• Dud E.A., Astrom A., Griffiths C.E., Chambon P., Voorhees J. Human skin levels of retinoic acid and cytochrome P-450 derived 4-Hydroxyretinoic acid after topical application of retinoic acid in vivi compared to concentrations required to stimulate retinoic acid mediated transcription in vitro. J. Clin. Invest. 1992; 90: 1269–1274
   PubMed Web of Science ®Google Scholar
• De Coster R., Wouter W., van Ginckel R., End D., Krekels M., Coene M.C., Bowden C. Experimental studies with liarozole (75 251) an antitumoral agent which inhibits retinoic acid breakdown. J. Steroid. Biochem. Molec. Biol. 1992; 43: 197–201
   PubMed Web of Science ®Google Scholar
• Francis P., Munidi J., Kris M., Young C., Orazem J., Warrell R.P., Jr. Modulation of all-trans retinoic acid metabolism by ketoconazole a cytochrome p-450 enzyme system inhibitor. Proc. Am. Assoc. 1993; 34: 392–392
   Google Scholar
• Dubois C., Schlageter M.A., de Gentilq Guidez A.F., Balitrand N., Toubert M.E., Fenaux P., Castaigne S., Najean Y., Degos L., Chomienne C. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 1994; 83: 3264–3270
   PubMed Web of Science ®Google Scholar
• Collins S.J., Robbertson K.A., Mueller L. Retinoic acid induced granulocytic differentiation of HL.-60 myeloid leukemia cells IS mediated directly through the retinoic acid receptor alpha. Mol. Cell. Biol. 1990; 10: 2154–2163
   PubMed Web of Science ®Google Scholar
• Graupner G., Malle G., Maignan G., Lang G., Prunieras Pfahl M. 6'-substituted naphtalene-2-carboxylic acid analogs a new class of retinoic acid receptor subtype-specific ligands. Biochem. Biophys. Res Commun. 1991; 179: 1554–1561
   PubMed Web of Science ®Google Scholar
• Robertson K.A., Emami B., Collins S. Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand binding domain that confers dominant negative activity. Blood 1992; 80: 1885–1889
   PubMed Web of Science ®Google Scholar
• Li Y.P., Said F., Gallagher R.E. Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-α. Blood 1994; 83: 3298–3302
   PubMed Web of Science ®Google Scholar
• Rottman J.N., Widom R.L., Nadal-Ginard B., Mahdavi V., Karathanasis S.K. A retinoic acid-responsive element in the apolipoprotein. A1 gene distinguishes between two different retinoic acid response pathways. Mol. Cell. Bid 1991; 11: 3814–3821
   Web of Science ®Google Scholar